Clinical Trial Update: Observational Study of Patients With Mucopolysaccharidosis (MPS) VI Who Previously Participated in ASB-00-02

View source ↗

Summary

This is a completed observational study of patients with Mucopolysaccharidosis type VI who previously participated in ASB-00-02, sponsored by BioMarin Pharmaceu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Vi

Drugs mentioned

• ASB-00-02

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: MPS VI | Status: COMPLETED